Tin Kyaw Selected Research

B-Cell Activation Factor Receptor

2/2017	Opposing roles of B lymphocyte subsets in atherosclerosis.
1/2013	BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.
1/2012	Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tin Kyaw Research Topics

Disease

18	Atherosclerosis 01/2021 - 10/2010
5	Myocardial Infarction 01/2021 - 02/2016
5	Inflammation (Inflammations) 11/2017 - 10/2011
4	Stroke (Strokes) 01/2021 - 02/2016
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 03/2013
2	Infections 12/2017 - 11/2017
2	Autoimmune Diseases (Autoimmune Disease) 11/2017 - 06/2012
2	Necrosis 02/2016 - 01/2015
2	Body Weight (Weight, Body) 01/2012 - 09/2011
1	Ischemic Stroke 01/2020
1	Rupture 02/2017
1	Gastritis 06/2012
1	Arteritis 01/2012
1	Hyperlipidemias (Hyperlipidemia) 10/2010

Drug/Important Bio-Agent (IBA)

11	Apolipoproteins E (ApoE)IBA 01/2021 - 10/2010
5	ApolipoproteinsIBA 01/2021 - 10/2010
5	LipidsIBA 01/2019 - 10/2010
5	Immunoglobulin M (IgM)IBA 01/2018 - 09/2011
4	CytokinesIBA 01/2018 - 10/2011
3	Immunoglobulin G (IgG)IBA 01/2021 - 02/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2018 - 01/2013
3	B-Cell Activation Factor ReceptorIBA 02/2017 - 01/2012
3	Granzymes (Granzyme)IBA 01/2015 - 03/2013
3	PerforinIBA 01/2015 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 02/2016
2	oxidized low density lipoproteinIBA 02/2017 - 11/2016
2	CholesterolIBA 02/2017 - 10/2011
2	InterferonsIBA 01/2015 - 03/2013
2	AntibodiesIBA 04/2014 - 01/2013
1	AlarminsIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	ChemokinesIBA 11/2017
1	Cytotoxins (Cytolysins)IBA 11/2017
1	Therapeutic UsesIBA 02/2017
1	phosphorylethanolamine (phosphoethanolamine)IBA 02/2016
1	AllergensIBA 02/2016
1	tesmilifene (DPPE)IBA 02/2016
1	PhosphatidylserinesIBA 06/2015
1	Liposomes (Liposome)IBA 06/2015
1	Interleukin-4 (Interleukin 4)IBA 01/2015
1	interleukin-21 (interleukin 21)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013
1	InterleukinsIBA 03/2013
1	H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)IBA 06/2012
1	CollagenIBA 09/2011
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2010

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2011
2	Splenectomy 01/2018 - 06/2015
1	Immunomodulation 12/2017
1	Immunotherapy 11/2017